Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIA1 | P42261 | 8/20 | 0.62 |
| ▸ | CHRNA1 | P02708 | 2/20 | 0.57 |
| ▸ | CHRNG | P07510 | 2/20 | 0.57 |
| ▸ | CHRNB1 | P11230 | 2/20 | 0.57 |
| ▸ | CHRND | Q07001 | 2/20 | 0.57 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.57 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.57 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.57 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.57 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.57 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.57 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2551823 | 0.99 | GRIA1 (0.61) | GRIA1CHRNA1CHRNGCHRNB1CHRND | |
| SCHEMBL398742 | 0.86 | CHRNA1 (0.64) | GRIA1CHRNA1CHRNGCHRNB1CHRND | |
| SCHEMBL9447580 | 0.84 | CHRNA1 (0.59) | GRIA1CHRNA1CHRNGCHRNB1CHRND | |
| SCHEMBL30420740 | 0.84 | TRPV1 (0.54) | GRIA1POLB | |
| SCHEMBL3400509 | 0.83 | TRPV1 (0.53) | GRIA1POLB | |
| SCHEMBL19365038 | 0.82 | HPGD (0.54) | POLB | |
| SCHEMBL15231167 | 0.81 | CA1 (0.68) | — | |
| SCHEMBL10422361 | 0.81 | L3MBTL1 (0.63) | — | |
| SCHEMBL5263499 | 0.80 | TRPV1 (0.57) | POLB | |
| SCHEMBL999773 | 0.79 | L3MBTL1 (0.70) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2397126-B1 | PHARMACEUTICAL COMPOSITION CONTAINING GLUR2-LACKING AMPAR ANTAGONIST FOR PREVENTING OR TREATING PSYCHIATRIC ILLNESSES | SNU R&DB FOUNDATION (KR) | 2014-11-19 | — | — | EP | claimed |
| US-8835503-B2 | Pharmaceutical composition containing GLUR2-lacking AMPAR antagonist for preventing or treating psychiatric illnesses | SNU R&DB FOUNDATION (KR) | 2014-09-16 | — | — | US | claimed |
| US-20130046023-A1 | PHARMACEUTICAL COMPOSITION CONTAINING GLUR2-LACKING AMPAR ANTAGONIST FOR PREVENTING OR TREATING PSYCHIATRIC ILLNESSES | SNU R&DB FOUNDATION (KR) | 2013-02-21 | — | — | US | claimed |
| US-20110105622-A1 | PHARMACEUTICAL COMPOSITION CONTAINING GLUR2-LACKING AMPAR ANTAGONIST FOR PREVENTING OR TREATING PSYCHIATRIC ILLNESSES | SNU R&DB FOUNDATION (KR) | 2011-05-05 | — | — | US | claimed |
| US-9062285-B2 | Compositions and methods for modulating AMPA receptor-mediated excitotoxicity | CT FOR ADDICTION & MEDICAL HEALTH (CA) | 2015-06-23 | — | — | US | disclosed |
| EP-2397126-B1 | PHARMACEUTICAL COMPOSITION CONTAINING GLUR2-LACKING AMPAR ANTAGONIST FOR PREVENTING OR TREATING PSYCHIATRIC ILLNESSES | SNU R&DB FOUNDATION (KR) | 2014-11-19 | — | — | EP | disclosed |
| US-8835503-B2 | Pharmaceutical composition containing GLUR2-lacking AMPAR antagonist for preventing or treating psychiatric illnesses | SNU R&DB FOUNDATION (KR) | 2014-09-16 | — | — | US | disclosed |
| EP-2719380-A2 | SUR1 inhibitors for therapy | University of Maryland, Baltimore (US) | 2014-04-16 | — | — | EP | disclosed |
| EP-2059598-B1 | COMPOSITIONS AND METHODS FOR MODULATING AMPA RECEPTOR-MEDIATED EXCITOTOXICITY | CAMH (CA) | 2014-03-19 | — | — | EP | disclosed |
| US-20130336951-A1 | COMPOSITIONS AND METHODS FOR MODULATING AMPA RECEPTOR-MEDIATED EXCITOTOXICITY | CENTRE FOR ADDICTION AND MENTAL HEALTH (CA) | 2013-12-19 | — | — | US | disclosed |
| US-8536115-B2 | Compositions and methods for modulating AMPA receptor-mediated excitotoxicity | CENTRE FOR ADDICTION AND MENTAL HEALTH (CA) | 2013-09-17 | — | — | US | disclosed |
| WO-2013102264-A1 | COMPOSITIONS AND METHODS FOR MODULATING AMPA RECEPTOR-MEDIATED EXCITOTOXICITY | CENTRE FOR ADDICTION AND MENTAL HEALTH (CA) | 2013-07-11 | — | — | WO | disclosed |
| US-20110105622-A1 | PHARMACEUTICAL COMPOSITION CONTAINING GLUR2-LACKING AMPAR ANTAGONIST FOR PREVENTING OR TREATING PSYCHIATRIC ILLNESSES | SNU R&DB FOUNDATION (KR) | 2011-05-05 | — | — | US | disclosed |
| US-7842471-B2 | Ultra sensitive biosensor for detecting bio-signal transmitters, and detector and detecting method using the same | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2010-11-30 | — | — | US | disclosed |
| US-20100210521-A1 | Compositions and methods for modulating ampa receptor-mediated excitotoxicity | CENTRE FOR ADDICITION AND MENTAL HEALTH | 2010-08-19 | — | — | US | disclosed |
| WO-2010033560-A2 | SUR1 INHIBITORS FOR THERAPY | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2010-03-25 | — | — | WO | disclosed |
| EP-2059598-A1 | COMPOSITIONS AND METHODS FOR MODULATING AMPA RECEPTOR-MEDIATED EXCITOTOXICITY | Centre for Addiction and Mental Health (CA) | 2009-05-20 | — | — | EP | disclosed |
| US-20090042234-A1 | ULTRA SENSITIVE BIOSENSOR FOR DETECTING BIO-SIGNAL TRANSMITTERS, AND DETECTOR AND DETECTING METHOD USING THE SAME | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2009-02-12 | — | — | US | disclosed |
| US-20080299109-A1 | MECHANISM OF ASTRICYTE-NEURON SIGNALING | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2008-12-04 | — | — | US | disclosed |
| WO-2008025163-A1 | COMPOSITIONS AND METHODS FOR MODULATING AMPA RECEPTOR-MEDIATED EXCITOTOXICITY | CENTRE FOR ADDICTION AND MENTAL HEALTH (CA) | 2008-03-06 | — | — | WO | disclosed |